Navigation Links
AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
Date:12/12/2012

WILMINGTON, N.C., Dec. 12, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.

(Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO)  

During his 20 year career at AAIPharma, Dr. Shirazi has helped AAIPharma excel in analytical chemistry and product development, most recently as vice president of analytical development.  With over 50 publications in scientific journals and a reference book in chromatography ("Fundamentals of Preparative and Nonlinear Chromatography, Second Edition"), Dr. Shirazi is a recognized expert in multiple types of liquid chromatography and gas chromatography.  Throughout his tenure, he has hired and trained a significant portion of laboratory personnel at AAIPharma, helping AAIPharma establish its leadership position in analytical chemistry and drug development.  In his new role, Dr. Shirazi will have responsibilities over the Wilmington and Durham analytical laboratories.   

"At AAIPharma, it has been an honor to work with thousands of clients throughout the industry," said Dr. Shirazi.  "My team and I look forward to continuing to help clients with their unique analytical challenges."

"The tenured analytical teams have long been the cornerstone of AAIPharma," said Patrick Walsh, Chief Executive Officer.  "As we continue to add new analytical capabilities in our new Wilmington Technology Center, Dr. Shirazi's analytical and regulatory expertise continues to be instrumental in coordinating our growth strategy."

Dr. Shirazi received his doctorate in analytical chemistry from Georgetown University. He conducted post-doctoral research at the University of Tennessee as a research associate, and his areas of interest are high performance liquid chromatography (HPLC), gas chromatography (GC), preparative chromatography, chiral separation and optimization of experimental conditions in chromatography.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit:
http://www.aaipharma.com.

For more information about our analytical development services, visit:
http://aaipharma.com/development/analytical-development

For more information about our analytical testing services, visit:
http://aaipharma.com/analytical-testing/

 


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Senior Director of Biopharmaceutical Development
2. AAIPharma Appoints Director Of Analytical Chemistry
3. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
4. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
5. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
6. River Vision Announces Completion of $17 million Series A Financing
7. Winner Medical Announces Closing of Going Private Transaction
8. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
9. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
10. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
11. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)...  Eli Lilly and Company (NYSE: LLY ) ... resolve pending patent litigation in the U.S. District Court for ... the Cialis ® (tadalafil) unit dose patent. This patent ... part of the agreement, Cialis exclusivity is now expected to ... "The unit dose patent for Cialis is valid and infringed ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... The Amnesty Rally 2017 will be ... Park at 3313 Bernstein Park Drive in Monroe (adjacent to the Louisiana Purchase Gardens ... help reduce gun violence throughout Monroe. Citizens can turn in unregistered, illegally-held and imitation ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... “Now Hiring!” ... St. Louis, Missouri. The company has achieved record-breaking sales for over 30 consecutive ... the next 12 months. , The upcoming year offers excitement and growth at HDIS, ...
(Date:7/25/2017)... Florida (PRWEB) , ... July 25, 2017 , ... ... Jennifer Haller, to the sales department joining as Regional Account Manager for the ... with contracted customers in the liquidation of their obsolete medical assets. , Jennifer ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, a locally ... across North Carolina, is launching a charity event in conjunction with the Triangle ... ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) operates ...
Breaking Medicine News(10 mins):